From 2012 to 2021, there was an increase in the prevalence of cannabinoid hyperemesis syndrome (CHS) in Massachusetts, with the highest 10-year prevalence among young adults, Hispanic individuals, Black individuals, and men, according to a study published in the American Journal of Gastroenterology.
This article was originally published on MedicalXpress.com

